Results 141 to 150 of about 50,827 (210)

Two centuries of <i>Pachyrhynchus</i> (Curculionidae, Entiminae, Pachyrhynchini) research: a comprehensive annotated checklist of taxonomy, species groups, distribution, and ecological insights in Southeast Asia. [PDF]

Zookeys
Ho Y, Chen SM, Amarga AKS, Tsai JF, Ho BH, Jeng ML, Tseng HY.   +6 more
europepmc   +1 more source

Gut microbiome is not associated with mild cognitive impairment in Parkinson's disease. [PDF]

NPJ Parkinsons Dis
Aho VTE, Klee M, Landoulsi Z, Heintz-Buschart A, Pavelka L, Leist AK, Krüger R, May P, Wilmes P, NCER-PD Consortium.   +9 more
europepmc   +1 more source

La fantasma de Valencia y las comedias de Fiestas del jardín de Alonso de Castillo Solórzano: hipótesis de datación y circunstancias de representación. [PDF]

Neophilologus, 2022
Monzó Ribes C, Blanco Campos F.
europepmc   +1 more source

Progression of <i>GBA1</i> severe and risk variants: a longitudinal mixed model analysis. [PDF]

Front Aging Neurosci
Hanff AM, McCrum C, Rauschenberger A, Pachchek S, Aguayo GA, Pauly C, Jónsdóttir SR, Tsurkalenko O, Pauly L, Landoulsi Z, Leist AK, May P, Zeegers MP, Krüger R.   +13 more
europepmc   +1 more source

Mild cognitive impairment is not associated with gut microbiota alterations in Parkinson’s disease

, 2023
Aho V, Klee M, Landoulsi Z, Heintz-Buschart A, Pavelka L, Leist A, Krüger R, May P, Wilmes P.   +8 more
europepmc   +1 more source

Dopamine Pathway and Parkinson's Risk Variants Are Associated with Levodopa-Induced Dyskinesia. [PDF]

Mov Disord
Sosero YL, Bandres-Ciga S, Ferwerda B, Tocino MTP, Belloso DR, Gómez-Garre P, Gómez-Garre P, Faouzi J, Taba P, Pavelka L, Marques TM, Gomes CPC, Kolodkin A, May P, Milanowski LM, Wszolek ZK, Uitti RJ, Heutink P, van Hilten JJ, Simon DK, Eberly S, Alvarez I, Krohn L, Yu E, Freeman K, Rudakou U, Ruskey JA, Asayesh F, Menéndez-Gonzàlez M, Pastor P, Ross OA, Krüger R, NCER‐PD Consortium, Corvol JC, Koks S, Mir P, De Bie RMA, Iwaki H, Gan-Or Z, International Parkinson's Disease Genomic Consortium.   +39 more
europepmc   +1 more source

Once-Monthly Long-Acting Injectable Aripiprazole for the Treatment of Patients with Schizophrenia and Co-occurring Substance Use Disorders: A Multicentre, Observational Study. [PDF]

Drugs Real World Outcomes, 2020
Szerman N, Basurte-Villamor I, Vega P, Martinez-Raga J, Parro-Torres C, Cambra Almerge J, Grau-López L, De Matteis M, Arias F.   +8 more
europepmc   +1 more source

Genotyping not required for sustained effectiveness of long-acting cabotegravir plus rilpivirine: evidence from the RELATIVITY cohort. [PDF]

AIDS
Buzón-Martín L, Bernardino JI, Galindo Puerto MJ, Martín-Torres J, Alemán Valls MR, Torralba González de Suso M, Díaz de Santiago A, Fanjul F, Rodríguez A, Cabello Úbeda A, Pedrero-Tomé R, Crusells Canales MJ, Calzado Isbert S, Aguilera García M, Hidalgo Tenorio C, Morano L, Vinuesa García D, de Andrés David C, Bernal Morell E, Martínez Álvarez RM, Cabello Clotet N, Tiraboschi J, Gimeno García A, Vivancos MJ, Troya J, the RELATIVITY Cohort Group .   +25 more
europepmc   +1 more source

Disease Surveillance during the Reintroduction of the Iberian Lynx (Lynx pardinus) in Southwestern Spain. [PDF]

Animals (Basel), 2021
Nájera F, Grande-Gómez R, Peña J, Vázquez A, Palacios MJ, Rueda C, Corona-Bravo AI, Zorrilla I, Revuelta L, Gil-Molino M, Jiménez J.   +10 more
europepmc   +1 more source

Comprehensive blood metabolomics profiling of Parkinson's disease reveals coordinated alterations in xanthine metabolism. [PDF]

NPJ Parkinsons Dis
de Lope EG, Loo RTJ, Rauschenberger A, Ali M, Pavelka L, Marques TM, Gomes CPC, Krüger R, Glaab E, NCER-PD Consortium.   +9 more
europepmc   +1 more source